Association between first-line monotherapy with sulfonylurea versus metformin and risk of all-cause mortality and cardiovascular events

All-cause mortality was significantly increased in patients prescribed sulfonylurea compared with metformin monotherapy (Diabetes, Obesity and Metabolism)